Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains

Jan Balzarini; W G Brouwer; Ethel E. Felauer; De Clercq Erik; Anna Karlsson

doi:10.1016/0166-3542(95)00006-8

Back

Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains

Article 1995 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1995

Structure-activity relationship studies for various oxathiin carboxanilide derivatives modified in the oxathiin moiety against wild-type and mutant human immunodeficiency virus type 1 strains

Jan Balzarini, W G Brouwer, D.C. Dao, Ethel E. Felauer, WilliamO. Harrison, De Clercq Erik, Anna Karlsson

Article1995

Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains

Jan Balzarini, Masanori Baba, De Clercq Erik

Article1989

Selective activity of several cholic acid derivatives against human immunodeficiency virus replication in vitro.

Masanori Baba, Dominique Schols, Hiroshi Nakashima, Rudi Pauwels, G. Parmentier, Dirk Meijer, De Clercq Erik

Article1996

Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1

José A. Esté, K De Vreese, Myriam Witvrouw, Jean‐Claude Schmit, Anne‐Mieke Vandamme, Jozef Anné, Jan Desmyter, Geoffrey Henson, Gary Bridger, De Clercq Erik

Article2003

Resistance development of human immunodeficiency virus-1 against diketo derivatives

Fikkert, Bénédicte Van Maele, Jo Vercammen, Barbara Van Remoortel, Martine Michiels, Christophe Pannecouque, Marc De Maeyer, Yves Engelborghs, De Clercq Erik, Zeger Debyser, Myriam Witvrouw